TITAN PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Titan Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Titan Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.09M, a 32% decline year-over-year.
  • Titan Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$5.46M, a 35.5% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$5.57M, a 45.4% increase from 2022.
  • Titan Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$10.2M, a 16.3% decline from 2021.
  • Titan Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$8.78M, a 51.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5.46M -$2.09M -$507K -32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 -$4.95M -$1.06M +$615K +36.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$5.57M -$1.97M +$596K +23.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$6.17M -$338K +$2.3M +87.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$8.47M -$1.59M +$876K +35.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 -$9.34M -$1.68M +$865K +34.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$10.2M -$2.57M -$26K -1.02% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$10.2M -$2.64M -$723K -37.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$9.46M -$2.46M -$782K -46.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$8.68M -$2.54M +$101K +3.82% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$8.78M -$2.54M +$545K +17.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$9.32M -$1.92M +$3.02M +61.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$12.3M -$1.68M +$2.96M +63.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$15.3M -$2.64M +$2.94M +52.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-11
Q4 2020 -$18.2M -$3.09M +$856K +21.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$19.1M -$4.93M -$2.13M -76% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17M -$4.64M +$556K +10.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$17.5M -$5.58M -$1.07M -23.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$16.5M -$3.94M -$437K -12.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16M -$2.8M -$758K -37.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$15.3M -$5.2M -$4.33M -498% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$10.9M -$4.52M -$1.91M -73.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$9.02M -$3.5M +$156K +4.26% Oct 1, 2018 Dec 31, 2018 10-K/A 2019-04-02
Q3 2018 -$9.18M -$2.05M +$2.15M +51.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$11.3M -$869K +$2.58M +74.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$13.9M -$2.61M +$400K +13.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$14.3M -$3.66M -$1.33M -57.3% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 -$13M -$4.19M -$1.57M -60% Jul 1, 2017 Sep 30, 2017 10-K/A 2019-04-02
Q2 2017 -$11.4M -$3.45M -$15.4M -129% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-04-02
Q1 2017 $3.98M -$3.01M -$1.16M -62.8% Jan 1, 2017 Mar 31, 2017 10-K/A 2019-04-02
Q4 2016 $5.14M -$2.33M -$33K -1.44% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $5.17M -$2.62M -$813K -45% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-02
Q2 2016 $5.98M $11.9M +$14.2M Apr 1, 2016 Jun 30, 2016 10-K 2018-04-02
Q1 2016 -$8.23M -$1.85M +$3.05M +62.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2015 -$11.3M -$2.29M -$1.82M -385% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$9.46M -$1.81M -$2.52M -352% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$6.94M -$2.28M -$1.44M -171% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$5.5M -$4.9M -$3.09M -171% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$2.4M -$473K -$264K -126% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$2.14M $716K +$1.86M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$4M -$842K -$5.91M -117% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 $1.91M -$1.8M -$7.81M -130% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 $9.71M -$209K +$71K +25.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $9.64M -$1.15M +$6.87M +85.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-31
Q2 2013 $2.77M $5.06M +$6.79M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-31
Q1 2013 -$4.02M $6M +$11.2M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-31
Q4 2012 -$15.2M -$280K +$2.62M +90.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$17.8M -$8.01M -$7.21M -897% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-31
Q2 2012 -$10.6M -$1.72M +$5.27M +75.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-31
Q1 2012 -$15.9M -$5.16M -$651K -14.4% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-31
Q4 2011 -$15.2M -$2.9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$804K -$420K -109% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$6.99M -$5.14M -279% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$4.51M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$384K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.85M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.